Global Strategy Lead, Rare Bone and Endocrine Disorders
Core
Lead the development and profitable management of the Hypophosphatasia (HPP) portfolio, focusing on commercialization strategy, disease strategy plans, and pre-launch planning for Top 21 countries.
Role type
Senior Global Brand Strategy Lead (Rare Disease)
Builds
Commercial strategies, disease strategy plans, and launch plans for rare bone and endocrine disorder products.
Domain
Rare disease pharmaceuticals (Hypophosphatasia)
Required skills
Strategic pre-launch planning, global market leadership, P&L management, drug development commercialization, stakeholder collaboration, financial business case building, regulatory compliance knowledge.
Preferred skills
Advanced degree (MBA/MSc/PhD), entrepreneurial mindset, cross-functional integration, inclusive environment creation.
Technologies
None stated
Responsibilities
Lead the Value Sub team to refine strategic value propositions; develop and roll out Disease Strategy Plans (DSP); drive Global Pre-Launch strategy 12-18 months prior to launch; develop long-range global forecasts; partner with R&D and BD for pipeline business cases.
Seniority
Senior, hands-on IC with leadership responsibilities
